You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anaplastic large cell lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Circular RNAs in ALKpositive Anaplastic Large-cell Lymphoma

Active, not recruiting
  • ALK-Positive Anaplastic Large Cell Lymphoma
  • RNAseq
  • Toulouse, France
    IUCT-Oncopole University Hospital
Jul 3, 2023

Anaplastic Large Cell Lymphoma, Vinorelbine Trial in Shanghai (Vinorelbine)

Completed
  • Anaplastic Large Cell Lymphoma
  • Vinorelbine
  • Shanghai, Shanghai, China
    Shanghai Children's Medical Center
Jul 23, 2022

Aggressive Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-Cell Lymphoma Trial in United States

Active, not recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +14 more
  • Cholecalciferol
  • Laboratory Biomarker Analysis
  • Scottsdale, Arizona
  • +4 more
Jan 16, 2023

DLBCL (DLBCL), Primary Mediastinal Large B-cell Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)

Active, not recruiting
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Relapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin Lymphoma Trial in Seoul

Completed
  • Relapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin Lymphoma
    • Seoul, Gangnam-Gu, Korea, Republic of
      Samsung Medical Center
    Feb 4, 2022

    Anaplastic Large Cell Lymphoma, ALK-Positive, Inflammatory Myofibroblastic Tumor, Other Solid Tumor Trial in Utrecht

    Recruiting
    • Anaplastic Large Cell Lymphoma, ALK-Positive
    • +2 more
    • Paris, France
    • +1 more
    Sep 27, 2022

    Recurrent Anaplastic Large Cell Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Mature T- and NK-Cell

    Active, not recruiting
    • Recurrent Anaplastic Large Cell Lymphoma
    • +10 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 30, 2023

    T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

    Recruiting
    • T-cell Lymphoma
    • +30 more
    • Optional Blood Sample
    • Optional Nail Sample
    • Duarte, California
    • +25 more
    Jul 28, 2023

    Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

    Not yet recruiting
    • Lymphoma, T-Cell, Cutaneous
    • +5 more
    • (no location specified)
    Nov 2, 2023

    Lymphoma Trial in Worldwide (cyclophosphamide, cytarabine, dexamethasone)

    Completed
    • Lymphoma
    • Vienna, Austria
    • +9 more
    May 24, 2022

    Anaplastic Large Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype, Recurrent Anaplastic Large Cell Lymphoma

    Recruiting
    • Anaplastic Large Cell Lymphoma
    • +19 more
    • Duarte, California
    • +2 more
    Aug 15, 2022

    ALK+ Anaplastic Large Cell Lymphoma Trial in Wien (Brentuximab vedotin, Imatinib)

    Terminated
    • ALK+ Anaplastic Large Cell Lymphoma
    • Wien, Austria
      Universitätsklinik f. Innere Medizin I, AKH Wien, Klinische Abte
    Feb 15, 2022

    T Lymphoblastic Leukemia/Lymphoma, T-cell Acute Lymphoblastic Leukemia, Peripheral T Cell Lymphoma Trial in Shanghai (anti-CD7

    Recruiting
    • T Lymphoblastic Leukemia/Lymphoma
    • +4 more
    • anti-CD7 CAR-T cells
    • Shanghai, China
      Xianmin General Song
    Aug 29, 2022

    Peripheral T Cell Lymphoma, PTCL, Extranodal NK/T-cell Lymphoma Trial in Worldwide (Tislelizumab)

    Completed
    Has Results
    • Peripheral T Cell Lymphoma
    • +18 more
    • Vancouver, British Columbia, Canada
    • +29 more
    Apr 29, 2022

    Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Grade IIIb Trial in Guangzhou (Toripalimab,

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • +5 more
    • Toripalimab, Rituximab
    • R-CHOP Protocol
    • Guangzhou, Guangdong, China
      Department of hematology department, Nanfang hospital
    Apr 6, 2022

    Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed

    Not yet recruiting
    • Pediatric Cancer
    • +11 more
    • anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
    • Milwaukee, Wisconsin
      Children's Wisconsin
    Sep 14, 2022

    Breast-implant ASsocIated anaplastIc Large Cell Lymphoma and

    Recruiting
    • Breast Implant-Associated Anaplastic Large Cell Lymphoma
    • +2 more
      • London, United Kingdom
      • +1 more
      Aug 17, 2021

      Anaplastic Large Cell Lymphoma, Peripheral T Cell Lymphoma, Extranodal NK/T-cell Lymphoma Trial in Duarte, Nashville, Houston

      Active, not recruiting
      • Anaplastic Large Cell Lymphoma
      • +4 more
      • Duarte, California
      • +3 more
      Jul 21, 2022

      T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

      Not yet recruiting
      • T-Cell Non-Hodgkin Lymphoma
      • +14 more
      • WU-CART-007
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jan 17, 2023

      Recurrent Anaplastic Large Cell Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Classic Hodgkin Lymphoma Trial in

      Recruiting
      • Recurrent Anaplastic Large Cell Lymphoma
      • +9 more
      • Anti-CD30/CD16A Monoclonal Antibody AFM13
      • +4 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 9, 2022

      Pediatric Anaplastic Large Cell Lymphoma Trial in Shanghai (P regimen, Course A1 + Vin, Course B1 +Vin)

      Recruiting
      • Pediatric Anaplastic Large Cell Lymphoma
      • P regimen
      • +7 more
      • Shanghai, China
        Shanghai Children's Medical Center
      Jul 23, 2022

      Extranodal Lymphoma or Lymphoma of Rare Pathological Types

      Not yet recruiting
      • Lymphoma
      • +8 more
      • No interventions need to be specified for this study
      • Shanghai, China
        Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
      Jun 15, 2023

      Anaplastic Large Cell Lymphoma, Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Refractory Mature T-Cell and NK-Cell

      Active, not recruiting
      • Anaplastic Large Cell Lymphoma
      • +2 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Duarte, California
      • +1 more
      Jul 26, 2022

      Recurrent Anaplastic Large Cell Lymphoma, Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Recurrent Primary Cutaneous

      Recruiting
      • Recurrent Anaplastic Large Cell Lymphoma
      • +8 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Apr 6, 2022

      Anaplastic Large Cell Lymphoma, Vinorelbine Trial in Shanghai (Vinorelbine)

      Recruiting
      • Anaplastic Large Cell Lymphoma
      • Vinorelbine
      • Shanghai, Shanghai, China
        Shanghai Children's Medical Center
      Jul 28, 2021